Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers.

[1]  P. Lipsky,et al.  Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. , 2002, Blood.

[2]  E. Estey,et al.  Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. , 2002, Leukemia research.

[3]  W. Vogel,et al.  Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. , 2002, Cancer research.

[4]  R. Salgia,et al.  Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells , 2002, Oncogene.

[5]  R. Siebert,et al.  Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. , 2002, Blood.

[6]  D. Metcalfe,et al.  Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. , 2002, The Journal of allergy and clinical immunology.

[7]  H. Deeg,et al.  Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. , 2001, Blood.

[8]  T. Tsuruo,et al.  Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent‐induced apoptosis , 2001, Journal of cellular physiology.

[9]  K. Lennert,et al.  Diagnostic criteria and classification of mastocytosis: a consensus proposal. , 2001, Leukemia research.

[10]  J. Bennett,et al.  Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis. , 2001, Leukemia research.

[11]  H. Nagawa,et al.  Expression of the ATF3 gene on cell lines and surgically excised specimens. , 2001, Oncology research.

[12]  Wei Zhang,et al.  Interaction of CR6 (GADD45γ) with Proliferating Cell Nuclear Antigen Impedes Negative Growth Control* , 2001, The Journal of Biological Chemistry.

[13]  K. Yoshitomo-Nakagawa,et al.  A Set of Hox Proteins Interact with the Maf Oncoprotein to Inhibit Its DNA Binding, Transactivation, and Transforming Activities* , 2001, The Journal of Biological Chemistry.

[14]  A. Gazdar,et al.  Abnormal expression of BRCA1 and BRCA1‐interactive DNA‐repair proteins in breast carcinomas , 2000, International journal of cancer.

[15]  F. Berthold,et al.  Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors. , 2000, Human molecular genetics.

[16]  W. El-Deiry,et al.  p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. , 2000, Biochemical and biophysical research communications.

[17]  L. Scott,et al.  Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. , 2000, Experimental Hematology.

[18]  A. Elson.  Protein tyrosine phosphatase ε increases the risk of mammary hyperplasia and mammary tumors in transgenic mice , 1999, Oncogene.

[19]  Li Yu,et al.  Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential , 1999, Clinical & Experimental Metastasis.

[20]  S. Hsieh,et al.  The Cytoplasmic Domain of the Lymphotoxin-β Receptor Mediates Cell Death in HeLa Cells* , 1999, The Journal of Biological Chemistry.

[21]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Heitjan,et al.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Reddy,et al.  Modulation of life and death by the TNF receptor superfamily , 1998, Oncogene.

[24]  D. Metcalfe,et al.  Clinical correlates of the presence of the asp816Val c‐kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis , 1998, Cancer.

[25]  P. Kiener,et al.  A role for tumour necrosis factor‐α, Fas and Fas‐Ligand in marrow failure associated with myelodysplastic syndrome , 1998, British journal of haematology.

[26]  S. S. Lee,et al.  Molecular cloning and localization of human syntaxin 16, a member of the syntaxin family of SNARE proteins. , 1998, Biochemical and biophysical research communications.

[27]  S. Orkin,et al.  Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. , 1997, Blood.

[28]  Laura H. Tang,et al.  Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm , 1996, Nature Genetics.

[29]  B. Zweiman,et al.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. , 1995, The Journal of clinical investigation.

[30]  Y. Suzuki,et al.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Preisler,et al.  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. , 1995, Blood.

[32]  K. Sakaguchi,et al.  Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. , 1995, Journal of immunology.

[33]  K. Kataoka,et al.  Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. , 1993, Oncogene.

[34]  D. Sugarbaker,et al.  Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Schwartz,et al.  Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. , 1987, Journal of immunology.

[36]  L. Schwartz,et al.  Evaluation of human peripheral blood leukocytes for mast cell tryptase. , 1987, Journal of immunology.

[37]  L. Schwartz,et al.  Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[39]  M. Gleave,et al.  Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin. , 2001, Neoplasia.

[40]  D. Campana,et al.  Copyright � 1995, American Society for Microbiology PITSLRE Protein Kinase Activity Is Associated with Apoptosis , 1994 .

[41]  A. Böyum,et al.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.